๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Ningbo
Clinical trial register · China

Clinical Trials in Ningbo

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Hangzhou 373 Huzhou 16 Ningbo 15 Shanghai 13 Hanzhou 13
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
First Affiliated Hospital of Ningbo University19 Second Affiliated Hospital, Zhejiang University, School of Medicine15 Ningbo Medical Center Lihuili Hospital10 Ningbo No. 1 Hospital8 Janssen Research & Development, LLC7 Clear sponsor filter
Site location
Hangzhou373 Huzhou16 Ningbo15 Shanghai13 Hanzhou13
All 69 locations
Target enrolment
to
15 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Fovinaciclib Plus Aromatase Inhibitors and Dual HER2 Blockade in a Response-Adapted Neoadjuvant Strategy for HR-Positive/HER2-Positive Early Breast Cancer
NCT07616427HR+/HER2+ Early Breast Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
100
Nanjing, Hangzhou, Ningbo
2026-05-20
Not yet open
24-Week Recurrence Rate of Gout Following Firsekibart Treatment
NCT07625514Gout Flare
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
264
Fuzhou, Hangzhou, Huzhou, Jinhua, Ningbo, Wenzhou
2026-05-07
Not yet open
Efficacy and Safety of Scheduled Versus As-Needed Firsekibart Administration for the Prevention of Gout Recurrence: A Multicenter, Open-Label, Randomized Controlled Trial
NCT07616531Gout Flares
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
118
Hangzhou, Fuzhou, Huzhou, Jinhua, Ningbo, Wenzhou
2026-05-01
Not yet open
Efficacy and Safety of Butylphthalide in the Treatment of Multiple System Atrophy
NCT07518810Multiple System Atrophy
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2/3
150
Nanning, Huzhou, Jiaxing, Ningbo, Taizhou, Beijing
2026-04-10
Recruiting
Ultrasound-Guided Intra-Articular vs Gluteal Intramuscular Corticosteroid Injection for Frozen Shoulder
NCT07416916Frozen Shoulder
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 4
528
Shanghai, Hangzhou, Huzhou, Jinhua, Ningbo, Shanhu
2026-02-23
Not yet open
ICSI Versus Conventional IVF in Couples With Unexplained Infertility
NCT07294027Unexplained Infertility
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
848
Beijing, Huangshi, Wuhan, Xiangyang, Hangzhou, Jiaxing, Ningbo
2026-01-01
Not yet open
Multicenter Prospective Non-randomized Controlled Study of ALA-PDT for LSIL With HPV16/18 Infection
NCT07306247HPV-16/18, Photodynamic Therapy (PDT), LSIL, Low Grade Squamous Intraepithelial Lesion
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
225
Hangzhou, Ningbo, Shaoxing
2026-01
Not yet open
Multicenter Prospective Non-randomized Controlled Study of Ella Photodynamic Therapy for Cervical HSIL/CIN2
NCT07306260HSIL, High Grade Squamous Intraepithelial Lesion, CIN 2, HPV (Human Papillomavirus)-Associated, Photodynamic Therapy (PDT)
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
560
Hangzhou, Ningbo, Shaoxing
2026-01
Recruiting
Orelabrutinib Combined With Rituximab as First-line Systemic Treatment for Marginal Zone Lymphoma
NCT07022223Marginal Zone Lymphoma(MZL)
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
51
Hangzhou, Dongyang, Huzhou, Jiaxing, Lishui, Ningbo, Quzhou, Shaoxing
2025-03-11
Recruiting
Efficacy and Safety of Telitacicept in the Treatment of Systemic Sclerosis
NCT06375005Diffuse Cutaneous Systemic Sclerosis
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
38
Yangzhou, Shanghai, Hangzhou, Huzhou, Jiaxing, Ningbo, Wenzhou
2025-01-06
Recruiting
Multicenter iTBS Neuromodulation for PTSD Treatment
NCT06434766Posttraumatic Stress Disorder
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
140
Shanghai, Hangzhou, Ningbo
2024-10-30
Recruiting
Intraventricular Administration of Intracranial Infections Caused by ๏ผˆCarbapenem-resistant Gram-negative Bacilli๏ผ‰CRGNB
NCT06595979Intracranial Infections
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
222
Hangzhou, Ningbo, Wenzhou
2024-06-25
Not yet open
Reverse Drilling Technique in Improving Outcomes After Arthroscopic Anterior Cruciate Ligament Reconstruction
NCT05994872Anterior Cruciate Ligament Injuries
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
216
Huzhou, Lishui, Meicheng, Ningbo, Shaoxing, Taizhou
2024-05-31
Recruiting
A Randomized Controlled Study Evaluating Modified Cup Anteversion Placement in Prevention of Postoperative Dislocation in Patients Undergoing Acetabular Tumor Resection and Reconstruction
NCT05593146Periacetabular Tumor
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
118
Ningbo
2023-04-13
Active, closed
Efficacy of taVNS Versus Sham Stimulation in Reduing Depressive Symptoms in Patients With Epilepsy: a Multi-center, Double-blinded, Randomized, 20-week, Parallel-arm, Superiority Study
NCT06794034Depressive Symptoms in Patients With Epilepsy
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
158
Hangzhou, Jiaxing, Jinhua, Ningbo, Yiwu
2023-04-01
Rows per page Showing 1–15 of 15
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 22 September 2026. https://priyalifescience.com/clinical-trials-china/city/ningbo

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.